Manitowoc Company (MTW) Carl Icahn Touch

New Post Public Reply Private Reply Replies (0) Message Board
riddock57

Keep a close eye on Manitowoc Company, Inc. (MTW). Billionaire investor Carl Icahn disclosed in a filing with the Securities and Exchange Commission a 7.77% stake in MTW, and said he plans to push the company to split its cranes and food-service equipment businesses into two separate companies

Mr. Icahn has not yet held talks with the company. He has amassed a stake of 10.5 million shares of MTW at a cost of about $146.6 million

MTW is a multi-industry, capital goods manufacturer with over 100 manufacturing, distribution, and service facilities in 24 countries. It is comprised of two segments – cranes and foodservice equipment

More about The Manitowoc Company, Inc. (MTW) at www.manitowoc.com.

**

Eclipse Resources Corp. (ECR) said that it has entered into an agreement to sell 62,500,000 shares of common stock for $440 million in a private placement transaction, which is expected to result in net proceeds to ECR of approximately $434 million (after deducting placement agent commissions and the Company’s estimated expenses). The shares will be sold to the investors at a purchase price of $7.04 per share.

ECR intends to use the net proceeds from the private placement to fund its capital expenditure plan and for general corporate purposes.

ECR also reported that its Board of Directors has approved a capital budget for 2015 of $640 million, a decrease of 20% from its 2014 capital budget. As of result of the Company’s improvement in capital and drilling efficiencies, ECR expects to deliver year-over-year production growth of 240 – 290% in 2015. ECR expects that net production for 2015 will consist of approximately 60% natural gas, 20% condensate and oil, and 20% natural gas liquids.

ECR is an independent exploration and production Company engaged in the acquisition and development of oil and natural gas properties in the Appalachian Basin, including the Utica and Marcellus Shales.

More about Eclipse Resources Corp. (ECR) at www.eclipseresources.com

**

Crown Equity Holdings Inc. (CRWE) provides marketing solutions that boost customer awareness and merchant visibility on the Internet

The company is currently developing its CRWE Network ( www.CRWE-PR.com ), a growing network of community targeted sites.

It has recently included Santa Ana, the county seat and second most populous city in Orange County, California ( www.santaana.crwe-pr.com ) to the CRWE Network.

Santa Ana is located in Southern California on the Santa Ana River, ten miles away from the California coast. It is only forty minutes southeast of Los Angeles. Santa Ana is home to two Fortune 500 companies, including Ingram Micro, and First American Corp. Santa Ana is also home to the famous guitar manufacturer, Rickenbacker International Corporation.

The City of Santa Ana had an estimated population in 2013 (U.S. Census Bureau) of 334,227, and represents an important marketplace for the CRWE Network, which business model is based on selling advertising to businesses targeting both locally and nationally

One of the primary goals of the CRWE Network is to offer business owners the power of consumer targeting advertisements on a local and national scale.

The CRWE Network has reached the 1486th community website in the U.S., associated with 3456 ZIP Codes, and includes coverage in the states of California, Mississippi, Michigan, Florida, Nevada and New York, as well as across 10 provinces in Canada.

Online video is gaining strength as a source for content marketing. Strategic plans are being developed for CRWE’s division CRWE Tube ( www.crwetube.com ) to improve the potential future growth for the company.

Together with its digital network of websites, CRWE provides and offers advertising branding, marketing solutions and services to boost customer awareness, as well as merchant visibility as a worldwide online multi-media publisher.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

Disclaimer: This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at CRWE-PR Finance www.finance.crwe-pr.com/disclaimer

Manitowoc Company (MTW) Stock Research Links

MTW Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 148

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 347

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 53

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 0

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading

Top 5 Most Recently Viewed Articles

Infosys: Leading Innovation and Growth in IT Services

Updated Category News Views 139

Infosys: Fastest Growing IT Services Brand Infosys, a standout leader in the realm of digital services, has recently been hailed as the fastest-growing IT services brand. Their extraordinary annual growth rate of 15% in brand value is a testament to their robust market strategies and trusted services. Recognition by Brand Finance The prestigious brand valuation firm Brand...

Continue Reading
Sanofi's Sarclisa Gains FDA Approval for First-Line Myeloma Care

Updated Category News Views 63

Sarclisa Gains FDA Approval: A New Hope Recently, Sarclisa, developed by Sanofi’s SA (NASDAQ: SNY), received pivotal FDA approval as a first-line treatment for adult patients with newly diagnosed multiple myeloma (NDMM) who are unable to undergo autologous stem cell transplantation (ASCT). This approval represents a significant breakthrough for those grappling with this...

Continue Reading
Rayonier Clarifies the Tax Implications of 2024 Dividends

Updated Category News Views 320

Understanding Rayonier's 2024 Dividend Tax Treatment Rayonier Inc. (NYSE: RYN), a prominent timberland real estate investment trust, has recently announced the tax implications associated with its 2024 dividend distributions on common stock. As a shareholder, grasping the tax treatment of these dividends is essential for effective financial planning. Dividend Overview and...

Continue Reading
Delta Airlines Eyes Strong Year-End Recovery Amid Challenges

Updated Category News Views 153

Delta Airlines Expects a Resilient Year-End Performance Delta Airlines Inc (NYSE: DAL) is navigating a challenging landscape yet remains optimistic about closing the year on a positive note. Following a significant technology failure this summer that impacted operations, the airline is poised to leverage the holiday travel surge to bolster its earnings. Impact of...

Continue Reading
Cyngn Secures $33 Million Funding to Propel Growth Strategy

Updated Category News Views 146

Cyngn Aims for Growth with New Funding Cyngn enters the new year with enthusiasm and significant momentum, fueled by its recent funding of $33 million aimed at enhancing production and deployment of its autonomous industrial vehicles. The focus is particularly on the DriveMod Tuggers and the highly anticipated DriveMod Forklifts, showcasing the company's commitment to...

Continue Reading